XU Rong-qin, XU Mei-ting ,YANG Yue. Discussion of Risk Evaluation and Mitigation Strategy of Rosiglitazone in America [J]. Chinese Journal of Pharmacovigilance, 2013, 10(12): 714-718.
[1] USA TODAY . Diabetes drug called heart death risk[ EB/OL ]. (2007-5-21)[2013-03-05]. http://usatoday30.usatoday.com/News/Health/2007-05-21-Avandia-diabetes_N.htm. [2] Nissen S E, Wolski K. Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes[J]. N Engl J Med ,2007,356(24):2457-2471. [3] USA TODAY. FDA review spotlights heart risk of diabetes pill [EB/OL].(2010-7-10)[2013-03-05].http://usatoday30.usatoday.com/news/topstories/2010-07-09-2283585147_x.htm. [4] FDA.CENTER FOR DRUG EVALUATION AND RESEARCH-Application Number:021071-APPROVAL LETTER[R/OL].(19995-25)[2013-03-05].http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/21071_Avandia_Approv.pdf. [5] FDA. Safety-Avandia(rosiglitazone)[EB/OL].(2007-5-21)[201303-05]. http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm150831.htm. [6] Nissen S E, Wolski K. Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes[J]. N Engl J Med ,2007,356(24):2457-2471. [7] FDA. FINAL MINUTES[R/OL].(2007-7-30)[2013-03-05]. http:// www.fda.gov/ohrms/dockets/ac/07/minutes/2007-4308m1-final.pdf. [8] FDA.WARNING LETTER-GlaxoSmithKline 25-Mar-08[EB/OL]. ( 2008-3-25) [2013-03-05]. http : //www . fda. gov/ICECI/EnforcementActions/WarningLetters/2008/ucm1048360.htm. [9] FDA.FDA Statement on Avandia TIDE Trial[EB/OL].(2010-7-21) [2013-03-05]. http://www.fda.gov/Drugs/DrugSafety/ucm219780.htm. [10] FDA. FDA NEWS RELEASE-FDA significantly restricts access to the diabetes drug Avandia[EB/OL].(2010-9-23)[2013-03-05]. http://www. fda . gov/NewsEvents/Newsroom/PressAnnouncements/2010/ucm226975.htm. [11] Calabresi M, Park A. After Avandia: Does the FDA Havea Drug Problem[EB/OL].(2010-8-10)[2013-03-05].http://www.time.com/time/health/article/0,8599,2010028,00.html. [12] FDA. FDA Issues Safety Alert on Avandia [EB/OL].(2007-5-21) [2013-03-05]. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm108917.htm. [13 ] FDA. FINAL MINUTES[R/OL].(2007-7-30)[2013-03-05]. http://www.fda.gov/ohrms/dockets/ac/07/minutes/2007-4308m1-final.pdf. [14] Department of Justice. GlaxoSmithKline to Plead Guilty and Pay $3 Billion to Resolve Fraud Allegations and Failure to Report Safety Data[EB/OL].(2012-7-2)[2013-03-05].http://www.justice.gov/opa/pr/ 2012/July/12-civ-842.html.